Morgan Stanley lends Werner and partners $150M for Pfizer HQ buy

Investor is teaming up with Deutsche Bank Asset Management and Alexandria Real Estate Equities to buy Midtown East buildings for $365M

New York /
Jul.July 11, 2018 10:14 AM

Left to right: Nicholas Moreau, Joel S Marcus, and James Gorman with 219 and 235 East 42nd Street (Credit: Wikipedia and Getty Images)

Morgan Stanley is providing David Werner and his partners $150 million to finance their purchase of Pfizer’s headquarters in Midtown East, sources told The Real Deal.

Werner teamed up with Deutsche Bank Asset Management and Alexandria Real Estate Equities, the California-based owner of offices and laboratories for life science tenants, to purchase Pfizer’s properties for $365 million.

Representatives for Werner and Deutsche Bank Asset Management could not be immediately reached.

Werner and Alexandria are buying the fee position on Pfizer’s 350,000-square-foot building at 219 East 42nd Street, which they will lease back to the pharmaceutical company for five years.

Alexandria will hold the majority interest in the property, and will have sole ownership after Pfizer’s lease expires. The loan from Morgan Stanley has a five-year term to coincide with the change in ownership.

Werner and Deutsche Bank’s asset management spinoff, meanwhile, are purchasing a leasehold on Pfizer’s larger building, the 825,000-square-foot 235 East 42nd Street. The asset manager will hold the controlling interest on the lease, which runs for another 40 years.

The acquisition is set to close later this week, according to Real Estate Alert, which first reported the news of Werner’s partners. A Cushman & Wakefield team led by Adam Spies, Doug Harmon, Josh King and Bob Knakal is brokering the sale of the buildings on behalf of Pfizer.

Alexandria developed the three-building Alexandria Center for Life Sciences complex at 430 East 42nd Street, but this is the real estate investment trust’s first building acquisition in the city. The purchase of the 10-story 219 East 42nd street values the property at $200 million.

Deutsche’s plans for its property are unclear. The 34-story building, finished in 1960, could be redeveloped into a larger building following the Midtown East rezoning.

Pfizer earlier this year signed a lease to relocate to 800,000 square feet at Tishman Speyer’s Spiral office building at 66 Hudson Boulevard, which enables construction to start.

Cushman & Wakefield’s Josh Kuriloff and Peyton Horn brokered the lease.


Related Articles

arrow_forward_ios
Steve Witkoff and Ian Schrager in front of the iconic PUBLIC hotel escalators. (PUBLIC, Getty)
EB-5 fund alleges Schrager, Witkoff siphoned money from Public Hotel
EB-5 fund alleges Schrager, Witkoff siphoned money from Public Hotel
Best Buy has closed about 20 of its big-box stores in each of the past two years (iStock)
Best Buy lays off 5,000 staffers, increases store closures
Best Buy lays off 5,000 staffers, increases store closures
Ryan Serhant and Gary Barnett on Development Slowdown in Pandemic
Coffee Talk: Extell’s Gary Barnett and Ryan Serhant
Coffee Talk: Extell’s Gary Barnett and Ryan Serhant
Cushman & Wakefield CEO Brett White
Cushman reports 10% drop in revenue in 2020
Cushman reports 10% drop in revenue in 2020
Central Queens Academy's Ashish Kapadia and United's Chris Jiashu Xu with a rendering of 88-08 Justice Avenue (Linkedin, iStock)
Charter school takes 85K sf in Queens condo building
Charter school takes 85K sf in Queens condo building
(IStock illustration by Kevin Rebong)
Smaller cities look to cash in on shift to remote work
Smaller cities look to cash in on shift to remote work
421-427 East 14th Street (Google Maps, iStock)
Stuy Town to get new 17K sf grocery store
Stuy Town to get new 17K sf grocery store
Photo illustration of Mayor Bill de Blasio as Uncle Sam (iStock, Getty/Illustration by Kevin Rebong)
NYC has $1.3B in unpaid property taxes
NYC has $1.3B in unpaid property taxes
arrow_forward_ios

The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

Loading...